An analysis of bacteraemia in a university hospital in Japan over a 10-year period. 1994

Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.

Details of positive blood cultures obtained from 357 inpatients attending the Toyama University Hospital were collected over a 10-year period in order to document changes in microbiological and clinical features of bacteraemia. Fifty-one per cent of patients were over 60 years old, 48% had intravascular catheters in-situ, and 17% had had surgical procedures within 30 days prior to the isolation of organisms from the blood. The proportion of underlying diseases other than malignancies increased over the 10-year period (42-60%, P < 0.05). Patients from surgical departments other than the Academic Department of Surgery increased over the study period (16-55%, P < 0.05). Staphylococcus aureus bacteraemia increased significantly (29 to 49%, P < 0.05) as did pseudomonas and anaerobic bacteraemia. Most bacteria showed no significant changes in their antibiotic sensitivity pattern over the 10 years. Clinical features in patients with bacteraemia varied with the infective organisms and the underlying disease. Mortality was high in patients with haematological malignancy, usually in association with Pseudomonas aeruginosa.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D005260 Female Females
D006785 Hospitals, University Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research. University Hospitals
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
April 2018, Enfermedades infecciosas y microbiologia clinica (English ed.),
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
January 1988, Reviews of infectious diseases,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
November 2023, Internal medicine journal,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
May 1996, Enfermedades infecciosas y microbiologia clinica,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
January 1993, In vivo (Athens, Greece),
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
January 2000, West African journal of medicine,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
May 1990, Journal of endodontics,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
March 2024, European journal of trauma and emergency surgery : official publication of the European Trauma Society,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
July 2001, International journal of antimicrobial agents,
Y Mizushima, and A Kawasaki, and H Hirata, and Y Daimon, and R Oosaki, and S Morinaga, and M Kobayashi
March 2004, The Journal of rheumatology. Supplement,
Copied contents to your clipboard!